INDBInternet News Database 2.5 Updated 2 min ago · 324 sources Show or hide images Light or dark

RSV Vaccine Cuts Lower Respiratory Disease in Older Adults

Save Like Comments Compare coverage

Summary

A phase 3 trial shows that a single-dose adenovirus vector RSV vaccine reduces the risk for lower respiratory tract disease by about 73% in adults aged 60 years or older.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    RSV Vaccine Cuts Lower Respiratory Disease in Older Adults

    A phase 3 trial shows that a single-dose adenovirus vector RSV vaccine reduces the risk for lower respiratory tract disease by about 73% in adults aged 60 years or older.

Comments

Comments need JavaScript.